切换至 "中华医学电子期刊资源库"

中华普通外科学文献(电子版) ›› 2024, Vol. 18 ›› Issue (01) : 58 -61. doi: 10.3877/cma.j.issn.1674-0793.2024.01.011

综述

肿瘤相关中性粒细胞在胃癌发生发展和治疗中的研究进展
尚峰进, 陈陆尧, 刘亚星, 张浩然, 连长红()   
  1. 046000 长治医学院附属和平医院胃肠外科;046000 长治医学院第一临床学院
    046000 长治医学院附属和平医院胃肠外科
  • 收稿日期:2023-06-16 出版日期:2024-02-01
  • 通信作者: 连长红
  • 基金资助:
    山西省研究生实践创新项目(2023SJ304)

Research progress on tumor associated neutrophils in the occurrence, development, and treatment of gastric cancer

Fengjin Shang, Luyao Chen, Yaxing Liu, Haoran Zhang, Changhong Lian()   

  1. Department of General Surgery, Heping Hospital Affiliated to Changzhi Medical College, Changzhi 046000, China; The First Clinical College of Changzhi Medical College, Changzhi 046000, China
    Department of General Surgery, Heping Hospital Affiliated to Changzhi Medical College, Changzhi 046000, China
  • Received:2023-06-16 Published:2024-02-01
  • Corresponding author: Changhong Lian
引用本文:

尚峰进, 陈陆尧, 刘亚星, 张浩然, 连长红. 肿瘤相关中性粒细胞在胃癌发生发展和治疗中的研究进展[J]. 中华普通外科学文献(电子版), 2024, 18(01): 58-61.

Fengjin Shang, Luyao Chen, Yaxing Liu, Haoran Zhang, Changhong Lian. Research progress on tumor associated neutrophils in the occurrence, development, and treatment of gastric cancer[J]. Chinese Archives of General Surgery(Electronic Edition), 2024, 18(01): 58-61.

迄今为止,胃癌的发病机制尚未完全明了。研究表明,肿瘤微环境(TME)对于肿瘤的发生和发展至关重要。TME中的肿瘤相关中性粒细胞(TANs)参与肿瘤进展的所有阶段,包括肿瘤起始、转移和免疫抑制,其复杂的作用机制增加了治疗胃癌的困难。随着对TME的深入研究,特异的治疗措施有望成为胃癌治疗的新希望。本文通过近年来文献回顾,研究和总结TANs在胃癌发生和转移中所起的作用,并阐述未来免疫治疗的发展方向,以期为临床和科研提供参考。

So far, the pathogenesis of gastric cancer (GC) has not been fully understood. Research shows that tumor microenvironment (TME) is essential for the occurrence and development of tumors. Tumor associated neutrophils (TANs) in TME are involved in all stages of tumor progression, including tumor initiation, metastasis, and immunosuppression. Due to the complex mechanism of TANs, the treatment of GC faces great challenges. With in-depth research on TME, specific treatment measures are expected for clinical treatment of GC. This article intends to review the literature in recent years, study and summarize the role of TANs in the occurrence and metastasis of GC, and briefly describe the development direction of targeted therapy in the future, trying to provide reference for clinical and scientific research.

[1]
Liu S, Deng Z, Zhu J, et al. Gastric immune homeostasis imbalance: An important factor in the development of gastric mucosal diseases[J]. Biomed Pharmacother, 2023, 161: 114338.
[2]
de Visser KE, Joyce JA. The evolving tumor microenvironment: from cancer initiation to metastatic outgrowth[J]. Cancer Cell, 2023, 41(3): 374-403.
[3]
Siwicki M, Pittet MJ. Versatile neutrophil functions in cancer[J]. Semin Immunol, 2021, 57: 101538.
[4]
Li S, Cong X, Gao H, et al. Tumor-associated neutrophils induce EMT by IL-17a to promote migration and invasion in gastric cancer cells[J]. J Exp Clin Cancer Res, 2019, 38(1): 177.
[5]
Wu L, Saxena S, Awaji M, et al. Tumor-associated neutrophils in cancer: going pro[J]. Cancers (Basel), 2019, 11(4): 564.
[6]
Coffelt SB, Wellenstein MD, de Visser KE. Neutrophils in cancer: neutral no more[J]. Nat Rev Cancer, 2016, 16(7): 431-446.
[7]
Sağlam , Civan HA. Impact of chronic Helicobacter pylori infection on inflammatory markers and hematological parameters[J]. Eur Rev Med Pharmacol Sci, 2023, 27(3): 969-979.
[8]
Cani PD, Jordan BF. Gut microbiota-mediated inflammation in obesity: A link with gastrointestinal cancer[J]. Nat Rev Gastroenterol Hepatol, 2018, 15(11): 671-682.
[9]
Que H, Fu Q, Lan T, et al. Tumor-associated neutrophils and neutrophil-targeted cancer therapies[J]. Biochim Biophys Acta Rev Cancer, 2022, 1877(5): 188762.
[10]
牛世伟, 龚红霞, 付晓燕, 等. IL-17及其介导的信号通路在胃癌中的研究进展[J]. 医学研究生学报, 2022, 35(6): 660-663.
[11]
Mei H, Wang D, Zhang Y. The tumor-associated neutrophils secrete LOX and MMP to promote tumor angiogenesis in gastric cancer bearing mice model[C]//第十七届国际免疫学大会, 北京, 2019[2023-06-16].
[12]
Mao Z, Zhang J, Shi Y, et al. CXCL5 promotes gastric cancer metastasis by inducing epithelial-mesenchymal transition and activating neutrophils [J]. Oncogenesis, 2020, 9(7): 63.
[13]
Zhang W, Gu J, Chen J, et al. Interaction with neutrophils promotes gastric cancer cell migration and invasion by inducing epithelial-mesenchymal transition[J]. Oncol Rep, 2017, 38(5): 2959-2966.
[14]
Zhang X, Shi H, Yuan X, et al. Tumor-derived exosomes induce N2 polarization of neutrophils to promote gastric cancer cell migration[J]. Mol Cancer, 2018, 17(1): 146.
[15]
Wang Y, Li X, Zhang T, et al. Neutrophils promote tumor invasion via FAM3C-mediated epithelial-to-mesenchymal transition in gastric cancer[J]. Int J Biol Sci, 2023, 19(5): 1352-1368.
[16]
Shan ZG, Chen J, Liu JS, et al. Activated neutrophils polarize protumorigenic interleukin-17A-producing T helper subsets through TNF-α-B7-H2-dependent pathway in human gastric cancer[J]. Clin Transl Med, 2021, 11(6): e484.
[17]
Wang TT, Zhao YL, Peng LS, et al. Tumour-activated neutrophils in gastric cancer foster immune suppression and disease progression through GM-CSF-PD-L1 pathway[J]. Gut, 2017, 66(11): 1900-1911.
[18]
Zhao Y, Bai Y, Shen M, et al. Therapeutic strategies for gastric cancer targeting immune cells: future directions [J]. Front Immunol, 2022, 13: 992762.
[19]
Basu A, Ramamoorthi G, Albert G, et al. Differentiation and regulation of T(H) cells: A balancing act for cancer immunotherapy[J]. Front Immunol, 2021, 12: 669474.
[20]
Keeley T, Costanzo-Garvey DL, Cook LM. Unmasking the many faces of tumor-associated neutrophils and macrophages: considerations for targeting innate immune cells in cancer[J]. Trends Cancer, 2019, 5(12): 789-798.
[21]
Powell D, Lou M, Barros Becker F, et al. Cxcr1 mediates recruitment of neutrophils and supports proliferation of tumor-initiating astrocytes in vivo[J]. Sci Rep, 2018, 8(1): 13285.
[22]
Giese MA, Hind LE, Huttenlocher A. Neutrophil plasticity in the tumor microenvironment[J]. Blood, 2019, 133(20): 2159-2167.
[23]
Liu Q, Yu S, Li A, et al. Targeting interlukin-6 to relieve immunosuppression in tumor microenvironment[J]. Tumour Biol, 2017, 39(6): 1010428317712445.
[24]
Zhang Y, He S, Xu C, et al. An activatable polymeric nanoprobe for fluorescence and photoacoustic imaging of tumor-associated neutrophils in cancer immunotherapy[J]. Angew Chem Int Ed Engl, 2022, 61(27): e202203184.
[1] 陈海涛, 章敬尧, 朱冰, 管佳佳, 傅军. 血清循环DNA在胃癌中的诊断及预后的价值[J]. 中华普通外科学文献(电子版), 2024, 18(01): 18-22.
[2] 李越洲, 张孔玺, 李小红, 商中华. 基于生物信息学分析胃癌中PUM的预后意义[J]. 中华普通外科学文献(电子版), 2023, 17(06): 426-432.
[3] 张俊, 罗再, 段茗玉, 裘正军, 黄陈. 胃癌预后预测模型的研究进展[J]. 中华普通外科学文献(电子版), 2023, 17(06): 456-461.
[4] 王得晨, 杨康, 杨自杰, 归明彬, 屈莲平, 张小凤, 高峰. 结直肠癌微卫星稳定状态和程序性死亡、吲哚胺2,3-双加氧酶关系的研究进展[J]. 中华普通外科学文献(电子版), 2023, 17(06): 462-465.
[5] 曹长青, 郭新艳, 高源, 张存, 唐海利, 樊东, 杨小军, 张松, 赵华栋. 肿瘤微环境参与介导HER2阳性乳腺癌曲妥珠单抗耐药的研究进展[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 90-95.
[6] 莫波, 王佩, 王恒, 何志军, 梁俊, 郝志楠. 腹腔镜胃癌根治术与改良胃癌根治术治疗早期胃癌的疗效[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 644-647.
[7] 陈大敏, 曹晓刚, 曹能琦. 肥胖对胃癌患者手术治疗效果的影响研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 651-653.
[8] 邓新军, 李正明, 李文彬. 广东省医学会泌尿外科疑难病例多学科会诊(第14期)——左肾原发恶性肿瘤并发于肺癌并脑转移[J]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(01): 114-117.
[9] 朱迎, 赵征, 许达, 陆录, 殷保兵. 免疫检查点抑制剂治疗肝细胞癌的进展与展望[J]. 中华肝脏外科手术学电子杂志, 2024, 13(01): 5-10.
[10] 张占国. 靶向免疫治疗时代的肝癌肝切除术再思考[J]. 中华肝脏外科手术学电子杂志, 2024, 13(01): 11-15.
[11] 张宇, 余灵祥, 杨永平, 赵德希, 刁广浩, 杨木易, 赵亮, 刘佳, 李鹏, 张宁, 任辉. 原发性肝癌Ⅲa期降期后肝切除临床疗效分析[J]. 中华肝脏外科手术学电子杂志, 2024, 13(01): 78-82.
[12] 严帅, 岳志强, 赵江华, 陈琳, 吴金柱. 初始不可切除肝癌患者靶向免疫联合治疗后手术切除临床疗效[J]. 中华肝脏外科手术学电子杂志, 2024, 13(01): 83-87.
[13] 魏小勇. 原发性肝癌转化治疗焦点问题探讨[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 602-607.
[14] 张可, 闫琳琳, 王鹏飞, 章秀林, 赵帆, 胡守奎. 外泌体环状RNA在肿瘤免疫和癌症免疫治疗中的作用[J]. 中华临床医师杂志(电子版), 2023, 17(10): 1102-1108.
[15] 符梅沙, 周玉华, 李慧, 薛春颜. 淋巴细胞免疫治疗对复发性流产患者外周血T淋巴细胞亚群分布与PD1/PD-L1表达的影响及意义[J]. 中华临床医师杂志(电子版), 2023, 17(06): 726-730.
阅读次数
全文


摘要